AlphaMadera's AlphaVal page computes Agilent Technologies, Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag A as undervalued, fairly valued, or overvalued.

What is Agilent Technologies, Inc.'s fair value?

Fair value for A is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value A?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from A's most recent reported fundamentals.

A - Agilent Technologies, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $153.25 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong

Trading 40.7% above fair value

Current Price $134.29

Bear Case $76.37 43.1% downside ($76.37 - $134.29) / $134.29 = -43.1% $4.71 × 12x P/E

Fair Value $95.47 28.9% downside ($95.47 - $134.29) / $134.29 = -28.9% $4.71 × 15x P/E

Bull Case $114.56 14.7% downside ($114.56 - $134.29) / $134.29 = -14.7% $4.71 × 18x P/E

Adjust Assumptions

P/E Multiple

15.0x

Adjusted EPS

4.71$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 28.5x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $153.25 from 41 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $95.47 per share.

Warnings

ℹ Dividend-based valuation: $27.90 (below our primary estimate by 61%). Large gaps may signal the dividend doesn't reflect full earning power.

ℹ Wall Street's average price target is $153.25 (from 41 analysts). Our estimate is 54% below the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples